Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, NeuroPace Inc (NASDAQ: NPCE) closed at $11.07 down -1.42% from its previous closing price of $11.23. In other words, the price has decreased by -$1.42 from its previous closing price. On the day, 0.5 million shares were traded.
Ratios:
For a deeper understanding of NeuroPace Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.70 and its Current Ratio is at 6.63. In the meantime, Its Debt-to-Equity ratio is 3.01 whereas as Long-Term Debt/Eq ratio is at 2.93.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on May 28, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On January 21, 2025, UBS started tracking the stock assigning a Buy rating and target price of $17.
Wells Fargo Upgraded its Equal Weight to Overweight on March 14, 2024, whereas the target price for the stock was revised from $16 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when ORBIMED ADVISORS LLC sold 168,136 shares for $15.85 per share. The transaction valued at 2,665,333 led to the insider holds 3,238,199 shares of the business.
Morrell Martha sold 78,334 shares of NPCE for $1,074,844 on Feb 21 ’25. The CHIEF MEDICAL OFFICER now owns 81,993 shares after completing the transaction at $13.72 per share. On Feb 20 ’25, another insider, KCK LTD., who serves as the 10% Owner of the company, sold 5,270,845 shares for $9.40 each. As a result, the insider received 49,545,943 and left with 0 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.31 while its Price-to-Book (P/B) ratio in mrq is 14.94.
Stock Price History:
Over the past 52 weeks, NPCE has reached a high of $18.98, while it has fallen to a 52-week low of $5.45. The 50-Day Moving Average of the stock is -13.65%, while the 200-Day Moving Average is calculated to be 3.06%.
Shares Statistics:
A total of 32.75M shares are outstanding, with a floating share count of 22.82M. Insiders hold about 30.42% of the company’s shares, while institutions hold 61.07% stake in the company.
